Daniel V Kalinovsky
7PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Feb 27, 2026
GD2-Targeted Minibody-Drug Conjugates Match the Potency of IgG-Based ADCs in a Mouse Cancer Model.Daniel V Kalinovsky, Matvey M Titov, Irina V Kholodenko
|Oct 27, 2023
Targeting GD2-Positive Tumor Cells by Pegylated scFv Fragment-Drug Conjugates Carrying Maytansinoids DM1 and DM4.Daniel V Kalinovsky, Irina V Kholodenko, Elena V Svirshchevskaya
|Jan 21, 2023
Minibody-Based and scFv-Based Antibody Fragment-Drug Conjugates Selectively Eliminate GD2-Positive Tumor Cells.Daniel V Kalinovsky, Irina V Kholodenko, Alexey V Kibardin
|Jun 28, 2022
Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors.Daniel V Kalinovsky, Alexey V Kibardin, Irina V Kholodenko
|Jun 04, 2020
RNA Sequencing-Based Identification of Ganglioside GD2-Positive Cancer Phenotype.Maxim Sorokin, Irina Kholodenko, Daniel Kalinovsky
|Oct 27, 2019
Multimerization through Pegylation Improves Pharmacokinetic Properties of scFv Fragments of GD2-Specific Antibodies.Irina V Kholodenko, Daniel V Kalinovsky, Elena V Svirshchevskaya
Pageof 2
Frequent Collaborators
7 joint publications
Roman V Kholodenko
6 joint publications
Irina V Kholodenko
3 joint publications
Sergey S Larin
3 joint publications
Sergey M Deyev
2 joint publications
Mariya V Konovalova
2 joint publications
Elena V Svirshchevskaya
2 joint publications
Dmitry Yu Ryazantsev
1 joint publications
Tatyana Shamanskaya
1 joint publications
Igor I Doronin
